retatrutide nafld fatty liver study Researchers report promising results with retatrutide, which significantly reduced fat in some patients over several months. Excess liver fat causes metabolic dysfunction–associated steatotic liver disease (MASLD retatrutide nonalcoholic fatty liver disease

244 SIBO is more common in people with motility disturbances, low stomach acid production, and bowel obstruction

Selective GH stimulation thats commonly discussed as having minimal spillover into other pituitary hormones in research settings

Body Composition Changes Raw weight loss numbers do not capture the full picture of what happens to male and female bodies during Retatrutide treatment

Designate a clean, comfortable space for injections and keep alcohol swabs, an FDA-cleared sharps container, and your medication pen together

Ideal for staying hydrated throughout the day

doi: 10.1001/jamainternmed.2025.1133 55 Bagherzadeh-RahmaniBMarzettiEKaramiECampbellBIFakourianAHaghighiAHet al